Cargando…

T-box transcription factor TBX1, targeted by microRNA-6727-5p, inhibits cell growth and enhances cisplatin chemosensitivity of cervical cancer cells through AKT and MAPK pathways

Cervical cancer (CC) is the fourth most common cancers among women worldwide. T-box transcription factor 1 (TBX1), a member of the T-box family, has anti-tumor effects in some types of cancer, but its role in CC is yet unknown. The aim of this study is to investigate the functions and underlying mec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Haixia, Song, Mei, Sun, Xiaoyan, Zhang, Xin, Miao, Huayan, Wang, Yankui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806341/ https://www.ncbi.nlm.nih.gov/pubmed/33557670 http://dx.doi.org/10.1080/21655979.2021.1880732

Ejemplares similares

sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo
por: Ma, Guoliang, et al.
Publicado: (2015)

The T-box transcription factor, TBX3, is a key substrate of AKT3 in melanomagenesis
por: Peres, Jade, et al.
Publicado: (2014)

Deltonin enhances gastric carcinoma cell apoptosis and chemosensitivity to cisplatin via inhibiting PI3K/AKT/mTOR and MAPK signaling
por: Yang, Lin, et al.
Publicado: (2023)

BI6727, a polo-like kinase 1 inhibitor with promising efficacy on Burkitt lymphoma cells
por: Chen, Er, et al.
Publicado: (2020)

Establishment of the TBX-code reveals aberrantly activated T-box gene TBX3 in Hodgkin lymphoma
por: Nagel, Stefan, et al.
Publicado: (2021)

Cell fate determination in cisplatin resistance and chemosensitization
por: Luong, Khanh V., et al.
Publicado: (2016)

S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism
por: Zhao, Chuchu, et al.
Publicado: (2018)

METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE
por: Li, Ruyi, et al.
Publicado: (2021)

Eribulin alone or in combination with the PLK1 inhibitor BI 6727 triggers intrinsic apoptosis in Ewing sarcoma cell lines
por: WeiΔ, Lilly Magdalena, et al.
Publicado: (2017)

Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer
por: Amir, Sumaira, et al.
Publicado: (2016)

Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway
por: Gao, Ying, et al.
Publicado: (2020)

Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway
por: Li, Hong-Bo, et al.
Publicado: (2021)

TBX4 variants and pulmonary diseases: getting out of the ‘Box’
por: Haarman, Meindina G., et al.
Publicado: (2020)

Dual Targeting of Y-Box Binding Protein-1 and Akt Inhibits Proliferation and Enhances the Chemosensitivity of Colorectal Cancer Cells
por: Maier, Eva, et al.
Publicado: (2019)

Homo Sapiens (Hsa)-microRNA (miR)-6727-5p Contributes to the Impact of High-Density Lipoproteins on Fibroblast Wound Healing In Vitro
por: Bastaki, Khaled Mahmoud, et al.
Publicado: (2022)

In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
por: Mellish, K. J., et al.
Publicado: (1993)

Inactivation of AKT/NF-κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin
por: Dukaew, Nahathai, et al.
Publicado: (2020)

Function of the C. elegans T-box factor TBX-2 depends on SUMOylation
por: Huber, Paul, et al.
Publicado: (2013)

Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
por: Wu, Li-Mei, et al.
Publicado: (2021)

MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2
por: Liu, Yang, et al.
Publicado: (2017)

Metformin enhances the chemosensitivity of hepatocarcinoma cells to cisplatin through AMPK pathway
por: Dong, Hao, et al.
Publicado: (2017)

Dacomitinib improves chemosensitivity of cisplatin-resistant human ovarian cancer cells
por: Xu, Lei, et al.
Publicado: (2021)

MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4
por: Ning, Fang-ling, et al.
Publicado: (2014)

MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines
por: WANG, ZIRAN, et al.
Publicado: (2016)

Epigenetic Suppression of the T-box Subfamily 2 (TBX2) in Human Non-Small Cell Lung Cancer
por: Nehme, Eliana, et al.
Publicado: (2019)

PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer
por: Zhu, Haiyan, et al.
Publicado: (2016)

Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer
por: Chi, Ru-pin Alicia, et al.
Publicado: (2021)

MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016)

BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1
por: Gohda, Jin, et al.
Publicado: (2018)

The T-box transcription factor, TBX3, is sufficient to promote melanoma formation and invasion
por: Peres, Jade, et al.
Publicado: (2013)

Knockdown of HMGN5 increases the chemosensitivity of human urothelial bladder cancer cells to cisplatin by targeting PI3K/Akt signaling
por: Gan, Yu, et al.
Publicado: (2017)

Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
Publicado: (2021)

Naa10p Enhances Chemosensitivity to Cisplatin in Oral Squamous Cell Carcinoma Cells
por: Sun, Lichun, et al.
Publicado: (2021)

The effect of propofol on chemosensitivity of paclitaxel in cervical cancer cells
por: Jin, Yanshan, et al.
Publicado: (2023)

Effect of silencing the T-Box transcription factor TBX2 in prostate cancer PC3 and LNCaP cells
por: Du, Wen-Liang, et al.
Publicado: (2017)

Short hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cells
por: ZHU, KEXIU, et al.
Publicado: (2012)

Icariin enhances the chemosensitivity of cisplatin‑resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway
por: Jiang, Shaoyan, et al.
Publicado: (2019)

Tbx2 and Tbx3 Regulate the Dynamics of Cell Proliferation during Heart Remodeling
por: Ribeiro, Inês, et al.
Publicado: (2007)

Chemosensitizing and nephroprotective effect of resveratrol in cisplatin –treated animals
por: Osman, Abdel-Moneim M, et al.
Publicado: (2015)

Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
por: Gąsiorkiewicz, Bartosz Mateusz, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_699misj5cq64ai2u3e6tvr4hc0